Andere talen Vir Biotechnology, Inc.

Aandelen

VIR

US92764N1028

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 16-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
8,36 ^USD	-2,45%		-12,28%	-16,90%

13/03	Transcript : Vir Biotechnology, Inc. Presents at Barclays 26th Annual Global Healthcare Conference 2024, Mar-13-2024 07:30 AM
05/03	Vir Biotechnology voltooit de registratie in fase 2 van de studie naar chronische hepatitis delta eerder dan gepland	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024	11/04
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	25/03
Vir Biotechnology Completes Enrollment in Phase 2 Chronic Hepatitis Delta Trial Ahead of Schedule	05/03
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule	05/03
Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule	05/03
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences	26/02
Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences	23/02
Vir Biotechnology's Q4 Loss Widens, Revenue Declines	23/02
Vir Biotechnology, GSK Terminate Collaboration on Flu	22/02
Earnings Flash (VIR) VIR BIOTECHNOLOGY Reports Q4 Revenue $16.8M, vs. Street Est of $6.55M	22/02
Vir Biotechnology, Inc. and Glaxo Wellcome UK Limited Mutually Agrees to Terminate Collaboration on the Influenza Program Under the DCA	22/02
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results	22/02
Vir Biotechnology, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	22/02
Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer	20/02
Vir Biotechnology, Inc. Announces Phil Pang Will Step Down as Chief Medical Officer	20/02
Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024	01/02
North American Morning Briefing : Microsoft Kicks -2-	30/01
Vir Biotechnology to Eliminate Roles, Close Facilities to Cut Costs	13/12
Vir Biotechnology to cut about 75 jobs, shut some facilities	13/12
Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation	13/12

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Vir Biotechnology, Inc.

Aandelen

VIR

US92764N1028

Andere talen

Filters